Binod Dhakal, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Janssen
    Topic:
    Advisory board
    Date added:
    10/25/2021
    Date updated:
    08/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Sanofi
    Topic:
    Advisory board
    Date added:
    10/25/2021
    Date updated:
    08/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Natera
    Topic:
    Advisory board
    Date added:
    10/25/2021
    Date updated:
    08/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    GSK
    Topic:
    Honorarium
    Date added:
    10/25/2021
    Date updated:
    08/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Amgen
    Topic:
    Advisory board
    Date added:
    10/25/2021
    Date updated:
    08/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Celgene/BMS
    Topic:
    Honorarium
    Date added:
    10/25/2021
    Date updated:
    08/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other Business Ownership
    Ineligible company:
    Arcellx
    Topic:
    Advisory Board
    Date added:
    07/30/2023
    Date updated:
    08/13/2024
Return to Chicago Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice